FOXO3 and Hyperglycemia: Recent studies indicated that RSV treatment can increase SIRT1 deacetylase activity, subsequently decreasing the expression of acetylated-FoxO3a and inhibiting the oxidative stress caused by hyperglycemia both in vitro and in vivo (Wang et al., 2017).